NATR Financials: Revenue Breakdown, Margins & Competitor Comparison
Nature's Sunshine Products Inc (NATR) generates most of its revenue from the General Health segment, contributing 41.3% or $47.38M of total sales, followed by Digestive and Cardiovascular segments. The company demonstrates strong profitability with a gross margin of 72.52%, an operating margin of 4.30%, and a net margin of 3.65%, alongside a 12.32% Return on Equity. NATR, with a market capitalization of $462.55M, outperforms competitors like NAGE in gross margin but trails USNA.
MAR 10·24/7 Wall St.→
Wall Street Lifts Targets on Five Below, Ulta Beauty and Nature's Sunshine Ahead of Key Earnings Reports
Wall Street analysts have raised price targets on Five Below (FIVE), Ulta Beauty (ULTA), and Nature's Sunshine Products (NATR) ahead of their upcoming earnings reports, signaling confidence in their business momentum and execution. Barclays increased Five Below's target to $211, Canaccord Genuity lifted Ulta Beauty's to $799, and Nature's Sunshine's target was raised to $29. The revisions reflect analysts' positioning before the results, with varying degrees of implied upside for each company based on their current stock prices.
DEC 10·Yahoo Finance Singapore▲
Is Nature's Sunshine Products, Inc. (NASDAQ:NATR) Trading At A 32% Discount?
Nature's Sunshine Products, Inc. (NASDAQ:NATR) currently appears to be trading at a significant discount, with its share price of US$21.51 signalling it might be 32% undervalued compared to its estimated fair value of US$31.76. This valuation is based on a 2-stage Discounted Cash Flow (DCF) model and suggests that the company's future cash flows make it an attractive investment, especially given its peers are trading at a 77% premium on average. Investors are encouraged to consider the assumptions behind DCF models and explore other fundamental factors like management and potential risks.
